These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6491901)

  • 1. On the identification of Michaelis-Menten elimination parameters from a single dose-response curve.
    Godfrey KR; Fitch WR
    J Pharmacokinet Biopharm; 1984 Apr; 12(2):193-221. PubMed ID: 6491901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The deterministic identifiability of nonlinear pharmacokinetic models.
    Godfrey KR; Fitch WR
    J Pharmacokinet Biopharm; 1984 Apr; 12(2):177-91. PubMed ID: 6491900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Michaelis-Menten metabolite formation kinetics: equations relating area under the curve and metabolite recovery to the administered dose.
    Chow AT; Jusko WJ
    J Pharm Sci; 1990 Oct; 79(10):902-6. PubMed ID: 2280360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Michaelis-Menten elimination kinetics: areas under curves, steady-state concentrations, and clearances for compartment models with different types of input.
    Wagner JG; Szpunar GJ; Ferry JJ
    Biopharm Drug Dispos; 1985; 6(2):177-200. PubMed ID: 4005396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic parameter estimation by numerical algorithms and multiple linear regression: application to pharmacokinetics.
    Yeh KC; Kwan KC
    J Pharm Sci; 1979 Sep; 68(9):1120-4. PubMed ID: 501533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mathematical analysis and drug exposure evaluation of pharmacokinetic models with endogenous production and simultaneous first-order and Michaelis-Menten elimination: the case of single dose.
    Wu X; Nekka F; Li J
    J Pharmacokinet Pharmacodyn; 2018 Oct; 45(5):693-705. PubMed ID: 29987574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical considerations in the calculation of bioavailability of drugs exhibiting Michaelis-Menten elimination kinetics.
    Rubin GM; Tozer TN
    J Pharmacokinet Biopharm; 1984 Aug; 12(4):437-50. PubMed ID: 6527233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-pass effect: nonlinear concept comprising an explicit solution of integrated Michaelis-Menten equation.
    Keller F; Scholle J
    J Pharm Sci; 1981 Feb; 70(2):195-8. PubMed ID: 7205226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New and simple method to predict dosage of drugs obeying simple Michaelis-Menten elimination kinetics and to distinguish such kinetics from simple first order and from parallel Michaelis-Menten and first order kinetics.
    Wagner JG
    Ther Drug Monit; 1985; 7(4):377-86. PubMed ID: 4082237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational problems of compartment models with Michaelis-Menten-type elimination.
    Metzler CM; Tong DD
    J Pharm Sci; 1981 Jul; 70(7):733-7. PubMed ID: 7264916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Closed form solutions and dominant elimination pathways of simultaneous first-order and Michaelis-Menten kinetics.
    Wu X; Li J; Nekka F
    J Pharmacokinet Pharmacodyn; 2015 Apr; 42(2):151-61. PubMed ID: 25678215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a programmable calculator to determine steady-state levels of drugs eliminated by parallel first-order and Michaelis-Menten kinetics.
    Crow JW; Levy G
    Am J Hosp Pharm; 1978 Sep; 35(9):1075-7. PubMed ID: 696752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steady-state volume of distribution of two-compartment models with simultaneous linear and saturated elimination.
    Wu X; Nekka F; Li J
    J Pharmacokinet Pharmacodyn; 2016 Aug; 43(4):447-59. PubMed ID: 27405818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nonlinear physiologic pharmacokinetic model: I. Steady-state.
    Wagner JG; Szpunar GJ; Ferry JJ
    J Pharmacokinet Biopharm; 1985 Feb; 13(1):73-92. PubMed ID: 4020623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic analysis of drug concentration data obtained during repetitive drug administration.
    Colburn WA; Gibaldi M
    J Pharm Sci; 1977 Apr; 66(4):530-3. PubMed ID: 856973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of the Michaelis-Menten equation and its integrated form which are useful in pharmacokinetics.
    Wagner JG
    J Pharmacokinet Biopharm; 1973 Apr; 1(2):103-21. PubMed ID: 4764425
    [No Abstract]   [Full Text] [Related]  

  • 17. High performance enzyme kinetics of turnover, activation and inhibition for translational drug discovery.
    Zhang R; Wong K
    Expert Opin Drug Discov; 2017 Jan; 12(1):17-37. PubMed ID: 27784173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mathematical study on characteristics of the average steady-state for drugs obeying Michaelis-Menten elimination kinetics].
    Zhou HW
    Zhongguo Yao Li Xue Bao; 1986 Sep; 7(5):385-9. PubMed ID: 2954407
    [No Abstract]   [Full Text] [Related]  

  • 19. Computation of the explicit solution to the Michaelis-Menten equation.
    Beal SL
    J Pharmacokinet Biopharm; 1983 Dec; 11(6):641-57. PubMed ID: 6689584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical solution to the Michaelis-Menten equation.
    Veng-Pedersen P; Suaréz L
    J Pharm Sci; 1983 Dec; 72(12):1483-5. PubMed ID: 6663492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.